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Study Design and Setting: Evidence-based research is the use of prior research in a systematic and transparent way to inform a new
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research series, we describe how to apply an evidence-based research approach before starting a new study.
Results: Before a new study is performed, researchers need to provide a solid justification for it using the available scientific knowledge
as well as the perspectives of end users. The key method for both is to conduct a systematic review of earlier relevant studies.
Conclusion: Describing the ideal process illuminates the challenges and opportunities offered through the suggested evidence-based
research approach. A systematic and transparent approach is needed to provide justification for and to optimally design a relevant and
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4.0/).1. Introduction
This article is part of a series describing evidence-based
researchdthe use of prior research in a systematic and
transparent way to inform a new study so that it is
answering questions that matter in a valid, efficient, ands article under the CC BY license (http://creativecommons.org/licenses/by/
Fig. 1. The evidence-based research approach highlighting the steps
to be taken before a study is conducted.
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Key findings
 An evidence-based research approachdthe use of
existing evidence in a transparent and explicit
waydis needed to justify the need for and design
a new study.
What this adds to what was known?
 Researchers are given guidance on why and how to
use an evidence-based research approach to justify
and design a new study.
What are the implications and what should change
now?
 To ensure that only valuable studies are conducted
in future, researchers should adopt the evidence-
based research approach for justifying and
designing a new study.
accessible manner [1]. By prior research, we mean original
studies (also called primary studies), but even when plan-
ning a new systematic review (secondary study), the au-
thors should perform a comprehensive search for earlier
similar systematic reviews to avoid redundancy [2,3]. In
this second of a three-part series, we describe how using
the evidence-based research approach before starting a
study helps to ensure its value.
Funding agencies and research ethics committees are
key gatekeepers of the scientific process by reviewing
new study protocols to evaluate their validity. If the design
and chosen methods align with and seem appropriate to
answer the proposed research question, the study is judged
to be valid. In addition, if the recruitment of and all deal-
ings with human participants (and their data) is ethically
acceptable, the new study is usually approved and sup-
ported. However, a further ethical dimension needs to come
into focus before the new study is allowed to go ahead: Is
the proposed study worthwhile? Does it add true value?
The extreme circumstances of formulating an indictment
against the investigated physicians in the Nuremberg pro-
cesses (1946e47) after the Second World War led to the
formulation of an ethical code that included the following
statement [4]: ‘‘2. The experiment should be such as to yield
fruitful results for the good of society, unprocurable by any
other methods or means of study, and not random or unnec-
essary in nature.’’ As Benjamin Freedman states, ‘‘These
principles seem to require as ethical preconditions that the
study be of some value, and not simply be valid.’’ [4].
How can a new study be demonstrated to add value?
Emanuel et al. provided an answer by reversing the argu-
ment, stating that research that is not ‘‘socially or scientif-
ically valuable includes clinical research with
H. Lund et al. / Journal of Clinicnongeneralizable results, a trifling hypothesis, or substan-
tial or total overlap with proven results.’’ [5]. Hence, if
the relevant question raised by the new study has already
been answered elsewhere, or where a substantial or total
overlap exists with the available evidence base, the new
study is unnecessary and of limited value.
A systematic review of earlier studies that addresses
questions similar to the one to be investigated by the new
study can identify evidence gaps and the presence of an
’overlap with proven results’ [5]. This will help ensure that
any new study is necessary. However, judgments about
value should include not only the identification of an evi-
dence gap but also the perspectives of the end users,
ensuring that the new study is of relevance to those it af-
fects and to society. If an identified evidence gap cannot
be shown to be relevant (based on the perspectives of the
end users), it may not need to be filled. In addition, simi-
larly, a need identified by end users does not in itself consti-
tute a gap in our knowledge [6]. Today a number of tools
and approaches exist that help include end users’ perspec-
tives (see e.g., http://www.jla.nihr.ac.uk/; https://www.
involve.org.uk/; or https://www.patientslikeme.com/).
Other factors such as the availability of funding, access
to relevant technologies, and the competency of involved
researchers will also be strong determinants whether a
new study should be conducted, but an evidence-based
research approach should always be applied first.1.1. The operationalization of the evidence-based
research approach
To assess whether the new study would indeed be filling
an evidence gap, the existing evidence should be identified
and synthesized systematically and transparentlyd
currently this is performed by conducting a systematic re-
view of earlier studies that answer the same research
question.
The use of an evidence-based research approach during
the planning phase of a study can be illustrated as shown in
Figure 1.
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systematic review of earlier similar studies should be iden-
tified (and if need be updated) or conducted. In addition, a
systematic and transparent gathering of the relevant end
users’ perspectives should be undertaken.
If the answer is no to the question of value of the new
study, the figure shows that the researchers must consider
a new angle to the suggested research question or identify
another research question altogether, and then once more
consider the value of this new question. Only if the re-
searchers can clearly demonstrate that the intended study
will add value, that is, there is both a societal need for it
and it will fill a shown evidence gap should a new study
be planned and designed in more detail.2. Identifying gaps in the present knowledge
Any identification of an evidence gap related to a spe-
cific clinical question must be based on a systematic review
of earlier similar studies, to acquire an unbiased and trust-
worthy knowledge of the existing evidence, to avoid unnec-
essarily repeating a study for which the answer is already
known [7]. Previous studies also provide researchers the
opportunity to reflect on and determine the optimal study
designda duty they owe the patients participating in their
new study (see section 5 in the following).
Unfortunately, numerous metaresearch studies show
that researchers continue to perform unnecessarily redun-
dant research, when results from similar studies provide
adequate evidence to address the question [8e17]. It is
very rare that researchers use systematic reviews to
justify or design a new study [18e24]. Typically, they
refer only to a very small proportion of the original
similar studies [10,20,25e28], and there does not seem
to be a relationship between the number of earlier studies
available to refer to and the number of studies the re-
searchers actually cite. The reasons for selecting refer-
ences for a study seem to be subjective [29e31] and
based on preferences and strategic considerations rather
than on a systematic and transparent approach. Positive,Table 1. Key searchable resources for existing systematic reviews
Resource Link
Cochrane Library https://www.cochranelibrary.com
Campbell Collaboration Library https://campbellcollaboration.org
Epistemonikos https://www.epistemonikos.org/
Joanna Briggs Institute EBP Database https://joannabriggs.org/




Open Science Framework (httpssignificant, and supportive studies are much more
commonly cited than those that are negative, nonsignifi-
cant, or critical [28,32e37].2.1. Identifying an existing or preparing a new
systematic review when planning a new study
Conducting a systematic review from scratch demands
specialized knowledge, skills, and a considerable amount
of time [38,39] as well as additional expertise from subject
matter experts such as specialized librarians and statisti-
cians. An immense effort is put worldwide into preparing
systematic reviews and developing the underlying method-
ology. One great example here is Cochrane, which has laid
the foundations for gold standard systematic reviewing
since its launch in 1993 and continues to develop and
enhance the methods for the updating and preparation of
systematic reviews. A more recent development is the In-
ternational Collaboration for the Automation of System-
atic Reviews (ICASR, https://icasr.github.io/) [40] that is
stimulating and supporting technical initiatives to increase
the efficiency and speed of the systematic review process.
Most importantly, the number of globally published sys-
tematic reviews is growing rapidly [41], meaning that in
future, health researchers will have a higher chance to
identify and use existing systematic reviews for justifying
and designing their new study. Unfortunately, among these
is also an increasing number of irrelevant and redundant
reviews, making quality appraisal ever more important
[2,3].
Early on during the planning of a new study, health re-
searchers should establish whether a relevant systematic re-
view exists. Table 1 lists a number of recommended sites to
search for existing systematic reviews.
If a published systematic review evaluating the same
research question is identified, the next step is to determine
whether it is of sufficient quality by using tools such as risk
of bias in systematic reviews (ROBIS) [42] or AMSTAR-2
[43].
Once we know that we can have confidence in the results
of the systematic review, the researcher needs to evaluateSystematic review coverage
/ Health care interventions and diagnostic tests
/library.html Research related to crime and justice, education,
international development, knowledge translation
and implementation, nutrition, and social welfare
Cochrane and non-Cochrane systematic reviews and
overviews of reviews of health care research




Registered systematic reviews currently in progress
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ally applicable threshold for currency of reviews does not
exist, but a review based on a search within a year will,
in most cases, be current, whereas a review based on a
search older than 5 years will probably not be current.
Specifying a precise threshold would be misleading; the de-
cision must be based on an assessment using specialist
knowledge of the clinical field in which the research study
will take place and the speed at which its evidence base
evolves. If the systematic review is found to be out of date,
the researcher needs to initiate updating (either in-house or
outsourced) to identify, appraise, and incorporate more
recent studies to base the planning of the new study on a
comprehensive and up-to-date knowledge of all pre-
existing evidence.
Once all three components have been evaluated, so it is
determined that the systematic review is relevant for the
research question, up to date and of acceptable qualityd
and its conclusions call for further researchdthe researcher
can proceed to use it to justify their planned study and to
inform its design.
However, if no relevant and adequate systematic review
is found, the researcher needs to either prepare such a sys-
tematic review themselves or outsource the task to experts
for preparing systematic reviews. If the identified system-
atic review is of acceptable quality but outdated, the
researcher will need to update the search for original
studies. This is necessary to ensure that a study published
after the search date of the systematic review does not
negate the need for a new study.2.2. Interpreting the results from the identified
systematic review: is there an evidence gap?
When deciding if an evidence gap exists or not based on
the identified systematic review, health researchers should
consider three elements: the ethical element, the quality
grading of the evidence found in the systematic review,
and the use of statistical methods to support the decision
process.2.2.1. The ethical element
In 2000, Emanuel, Wendler, and Grady proposed seven
requirements for ethical clinical research studies [5]. In
addition to respect for the participants, informed consent,
independent review, a favorable risk ratio, fair subject se-
lection, and scientific validity, they also ask health re-
searchers to consider if the proposed research will
enhance knowledge or health, and therefore have value.
Their recommendations are formulated as two questions
to consider in determining if a new study is ethical [5]:
(a) Is the research question scientifically valid and not a
trifling hypothesis?
(b) Will it be possible to generalize the new results, that
is, beyond the sample and context of the study?2.2.2. Grading the quality of the existing evidence
When a systematic review is found, updated, or pre-
pared, the certainty of the evidence for the existing body
of evidence should be determined [44]. Several different
grading systems have been developed (see e.g., [44,45]).
If confidence in the conclusion is high, that is, if the quality
grading of the evidence indicates that the certainty of the
evidence is high, there is no need for a new study, but if
confidence is low or the evidence is insufficient, there is
a case to be made for a new study.
2.2.3. Additional statistical methods
The interest in deciding when a meta-analysis is conclu-
sive has led to the development of different statistical
methods. Besides the obvious use of the confidence inter-
val, other methods have been suggested such as the predic-
tion interval (Section 10.10.4.3 in [46]), funnel plots [47],
trial sequential analysis [48], and others (see examples in
[49]). The prediction interval, for example, includes the
heterogeneity of the included studies when calculating the
probable range within which the true effect lies (10.10.4.3
in [46]). One could argue that in cases with a broader pre-
diction interval compared with the confidence interval, the
underlying higher heterogeneity necessitates further
studies, that is, no further studies needed if the lower limit
of the prediction interval is higher than the minimal clinical
important difference threshold.
To sum up one can be fairly confident that a new study
needs to be carried out if the answers to the two ethical
questions are ‘‘yes’’, if the grading of the evidence for
the conclusion from the systematic review indicates that
the certainty of evidence is low or very low, and if statisti-
cal methods support low certainty of evidence. The final de-
cision whether to conduct a study will come down to a
nuanced consideration of the balance between the existing
evidence, the relevance of the topic, and the opportunity
cost of the research.
2.3. What if there are no earlier studies
During the early days of a new treatment or diagnostic
method, it can be difficult to identify any earlier similar
studies for the research in question. Even if the intervention
is genuinely new, a systematic review should be conducted.
It should be easy and fast to perform and appraise the re-
sulting search to conclusively document that no earlier
studies exist. In such cases, the main focus will be to make
sure that the intervention is relevant for end users and soci-
ety (see Section 3 in the following).
As stated in the explanation for CONSORT guidelines, it
would also be important to consider if any ‘‘plausible
explanation for how the intervention under investigation
might work, especially if there is little or no previous expe-
rience with the intervention’’ [50]. The example in Box 1
illustrates a possible approach in cases when no earlier
similar original studies can be found.
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Researchers are planning a randomized controlled
trial (RCT) for a recently developed physiotherapy
treatment for patients with balance deficits, for
example, due to sclerosis or Parkinsonism and want
to use an evidence-based research approach to justify
their study. They decide to perform a qualitative
study to obtain the perspectives of patients and clini-
cians who will either receive or prescribe this new
intervention (See Section 3 in the following) and a
scoping review to understand the present evidence
for other nonpharmacological treatments for
patients with balance deficits.
3. Establishing whether a new study is relevant
In addition to the identification of evidence gaps
through the use of systematic review, the need for a new
study should be justified by establishing that it is address-
ing a question relevant to its end users. In the health
context, end users usually encompass patients, caregivers,
and clinicians. Patients and their caregivers may often be
represented by national patient organizations (e.g., the
American Heart Organization or the Norwegian Rheu-
matic Association). In other circumstances, carefully
selected individuals, committees, or boards arranged by re-
searchers may be used to elicit patient perspectives. Like-
wise, clinicians also have their professional organizations
or can provide input as individuals invited to a panel or
a committee.
The US Patient-Centered Outcomes Research Institute
defines patient-relevant research as ‘‘the evaluation of
questions and outcomes meaningful and important to pa-
tients and caregivers. The definition rests on the axiom
that patients have unique perspectives that can change
and improve the pursuit of clinical questions.including
the perspectives of end users of the research, which
include patients, physicians, and other health care stake-
holders, will enhance the relevance of research to actual
health decisions these end users face’’ [51]. Within the
last 20 years, and accentuated within the last
5e10 years, funders, regulators, and others supporting
health research have been demanding the involvement of
end users in research.
Patients have first-hand lived experience providing
insight as to the most important matters in relation to a
study of a specific patient group. Numerous studies show
a discrepancy between what end users need and what re-
searchers focus on, indicating that researchers are very poor
at identifying or ignore the needs of end users when plan-
ning new research [52e59]. In addition, public funding of
research only modestly correlates with disease burden, if
at all [60e62].3.1. How to include the end user perspective?
The evidence-based research approach does not pre-
scribe any particular methodology for involving end users
in the research process but suggests that whatever is chosen
should be carried out systematically and transparently (see
Box 2). The optimal approach would be to conduct a sys-
tematic review of qualitative studies or surveys identifying
experiences and attitudes among patients or clinicians
about the disease and/or treatment, or diagnostic technique
in question.
The challenge of using systematic reviews of qualitative
studies or surveys is that the systematic review will most
probably not cover all necessary aspects of the project.
Thus, many health researchers have chosen to obtain end
users’ perspectives by inviting them to be a member of a
panel, committee, board, or even of the research group it-
self [63]. Unfortunately, this approach increases the risk
of a nonsystematic and nontransparent involvement of
end users. We therefore suggest to look for systematic re-
views of qualitative studies or surveys obtaining the per-
spectives of the relevant end users, even though currently
the number of such systematic reviews is sparse [64]
compared with that of systematic reviews of randomized
clinical trials [41].4. The interaction between identifying evidence gaps
and including end users’ perspectives
As illustrated in Figure 1, both the end user’s perspec-
tives and results of a relevant systematic review of similar
earlier studies need to be considered when aiming to estab-
lish the need for a new study. Moreover, the two elements
interact with each other. If end users are asked to identify
and prioritize the most relevant research questions, it would
only be fair to inform them about the existing evidence base
to avoid wasting time discussing research questions that
have already been answered. Methods such as the evidence
gap maps, systematic maps, evidence maps, evidence map-
ping and alike (see [65]) have been successfully used for
this purpose.
In cases where there are no earlier studies (like the case
with the new nonpharmacological treatment for balance
deficits among neurological patients, see Box 1), end users’
perspectives may well be the sole source for answering the
question regarding the value of a new study.5. Applying evidence-based research principles to the
design of a new study
Study design is determined by a range of methodolog-
ical options, such as the ways to collect and assign samples,
to collect and analyze data, and to use interventions and in-
struments. Applying an evidence-based research approach
will closely link the research question with the chosen
163al Epidemiology 129 (2021) 158e166Box 2
A new rehabilitation program for patients surviv-
ing a cardiac arrest was to be developed and tested.
The PhD student applied an evidence-based research
approach to planning and, instead of straightaway
designing a new randomized clinical trial, first pre-
pared the following three studies: The first study
was a national population-based survey aiming to
describe the self-reported prevalence of cognitive,
psychological, and physical problems in people sur-
viving a cardiac arrest and to analyze how these
change over time. The study provided information
about end users’ perspectives in a systematic and
transparent way. This could also have been achieved
by conducting a systematic review of earlier pub-
lished qualitative studies that had asked cardiac arrest
survivors what was important to them when it came
to their need for rehabilitation. The second study
was a systematic review of the evidence for the effec-
tiveness of nonpharmacological interventions, evalu-
ating different existing rehabilitation programs for
people with cardiac arrest. Based on the results of
the two initial studies, the PhD student prepared a
third study exploring the acceptability and feasibility
of a rehabilitation intervention designed for survivors
with cardiac arrest. Using an evidence-based research
approach helped to lay the firm foundations for future
randomized controlled trials.
methods and design, thereby ensuring that the new study is
valuable.
The justification process described previously is so
closely related to the design process that in practice the
two should not be performed separately. The justification
process reaches a binary conclusion, namely the study is
valuable, or it is not. If the new study does not add value,
there is no reason to progress to the design process. If the
new study is determined to be of value, the process leading
to this conclusion is the same as for designing the new
study.
5.1. Design informed by a systematic review
A systematic review will typically conclude with impli-
cations for practice and implications for research. In the
newest version of the Cochrane Handbook (Chp 15.6,
[46]), it is suggested to formulate the implications for
research in relation to the grading of the evidence. A frame-
work using a Population, Intervention, Comparison, Out-
comes (PICO) approach to characterize important aspects
of a possible evidence gap was published in 2011 [6].
Table 2 gives an example of such evidence gaps identified
through the synthesis of earlier studies in the Cochrane
H. Lund et al. / Journal of Clinicsystematic review about aquatic exercise for knee and hip
osteoarthritis from 2016 using Robinson’s framework
[6,66].6. Reporting
An inevitable question is how the applied evidence-
based research approach should be documented when the
study is being written up for publication. CONSORT
clearly recommends that the ‘‘need for a new trial should
be justified in the introduction. Ideally, it should include a
reference to a systematic review of previous similar trials
or a note of the absence of such trials’’ [67]. Even in the
first version of CONSORT [68], this issue was emphasized
butdas metaresearch is clearly indicatingdvery few au-
thors are following this guidance [10,22,24,69e72] and
very few journals are requesting, let alone enforcing it. Tak-
ing the example from Table 2, a new study aiming to meet
the identified evidence gaps listed in Bartels’ Cochrane re-
view should refer to and cite this systematic review when
providing a justification for the new study [66].
The introduction section could also be used to document
the process for determining the relevant components of
study design. In our example, authors might simply state
with regard to selected primary clinical outcomes that
‘‘there is moderate quality evidence that aquatic exercise
may have small, short-term, and clinically relevant effects
on patient-reported pain, disability, and QoL in people with
knee and hip osteoarthritis’’ [66]. Or they might mention
that the evidence has identified a number of gaps relating
to disease severity when justifying the study’s patient
groups. Authors of a new study protocol should not only
state the fact but also explain how the research question
and the design of the new study are justified and informed
by the perspectives of end users and the implications for
research in a relevant systematic review.
In cases where a study protocol is published, this would
be the optimal opportunity to report the evidence-based
research approach to study design, documenting the
reasoning around the study’s PICO selection and the prior-
itization of the identified evidence gaps in relation to the
clinical relevance for the patient and the practitioner in
much greater detail than in the final article summarizing
study results. One good example was a protocol for a sys-
tematic review on the impact of periodontal therapy on
measures of disease activity and actual inflammatory
burden in patients with rheumatoid arthritis. Its introduction
section included an evidence-based research component
providing a detailed description of the PICO question, the
information sources used, the results of the search, and
the implications of these results for the justification and
design of the new systematic review about this topic.
If ethic committees and funding agencies demanded
such an approach and level of information in the applica-
tions for ethical approval and financial support, this would
Table 2. The example of a Cochrane review on aquatic exercise for patients with knee and hip osteoarthritis [66] using Robinson’s framework to
identify evidence gaps [6]
Population (P) Intervention (I) Comparison (C) Outcome (O)
PICOPatients with knee and hip
osteoarthritis: - Severity of
disease (unclearly reported)
- use international standard for
defining a patient with knee and
hip osteoarthritis
Aquatic exercise:
- clear type of aquatic exercise
- design studies testi2ng
different exercise doses rele-
vant for clinical practice
Control:
- lack of studies
comparing often used
alternative treatments
Pain, function, and quality of life were measured,
but no studies have measured the effect of
aquatic exercise on fatigue
- measured immediately after the end of
treatment
- appropriate follow-up time
164 H. Lund et al. / Journal of Clinical Epidemiology 129 (2021) 158e166create a strong incentive to systematically and transparently
consider the relevance and necessity of any new study.
Apart from a few exceptions [73], funding agencies have
not yet implemented this requirement [74].7. Discussion
Although by itself it does not address all issues required
to demonstrate the value of new research, the evidence-
based research approach is a crucial part of the process of
justifying and designing a new study.
Proposing the evidence-based research approach to
justify and design new studies, we recognize that there
are a number of important challenges. First, as noted in
the introduction to this series (REF to EBR article #1),
many clinical researchersddespite being aware of system-
atic reviewsdlack the knowledge, skills, and time to
conduct one. Strongly related to this first challenge is the
current lack of incentive for researchers to prioritize the
preparation of a systematic review over actually starting
their new study. These challenges need to be tackled by
the wider research ecosystem and not seen purely as the re-
sponsibility of the individual researcher. Research institu-
tions and funding agencies, ethics committees, and
publishers need to adapt and remove barriers to the imple-
mentation of an evidence-based research approach. The
relevant training curricula and facilities need to be provided
to equip researchers with the necessary skills to identify
and use (and if need be update or conduct) systematic re-
views, and so facilitate the use of systematic reviews when
planning new studies.
Research waste due to the wrong questions being asked
by scientists, poor study design, inaccessible research, and
selective and biased reporting [75] is not only a matter of
redundant studies with no apparent value for research, prac-
tice, or end users, but also perpetuates irresponsible use of
funding resources and risks damaging the public’s trust in
research [76].
Therefore, how should these challenges of dissemination
and anchoring of evidence-based research be met? We
recommend structured and mandatory training in finding
and critically appraising systematic reviews at undergradu-
ate and postgraduate levels and the active empowerment ofmentors and supervisors by offering relevant training to se-
nior researchers during the transition period until the
evidence-based research approach is fully established.
Some might argue that our recommendations will place
a considerable burden of effort and time on researchers, but
as outlined in our series, the evidence-based research
approach is an absolute necessity to ensure valuable
research. The greatest waste and burden is to carry out a
completely unnecessary research study!Acknowledgments
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